Outcome predictors of cirrhotic patients with spontaneous bacterial empyema

Liver International

Volumn 31, Issue 3, 2011, Pages 417-424

  Chen, Chia Hung ^a   Shih, Chuen Ming ^a   Chou, Jen Wei ^a   Liu, Yi Heng ^a   Hang, Liang Wen ^a   Hsia, Te Chun ^a   Hsu, Wu Huei ^a   Tu, Chih Yen ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Cirrhosis; MELD score; MELD Na score; Spontaneous bacterial empyema

Indexed keywords

ALBUMIN; BILIRUBIN; CEFAZOLIN; CEFOTAXIME; FLOMOXEF; SULTAMICILLIN;

ADULT; ALBUMIN BLOOD LEVEL; ANAEROBE; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; BACTEREMIA; BACTERIAL PERITONITIS; BACTERIOLOGY; BACTERIUM ISOLATE; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CHILD PUGH SCORE; CONTROLLED STUDY; EMPYEMA; END STAGE LIVER DISEASE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; HYDROTHORAX; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SPONTANEOUS BACTERIAL EMPYEMA; STATISTICAL PARAMETERS; TERTIARY HEALTH CARE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMORBIDITY; EMPYEMA, PLEURAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYDROTHORAX; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLEURAL EFFUSION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAIWAN; TREATMENT FAILURE;

EID: 79551554578     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02447.x     Document Type: Article

References (27)

1. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multi-organ failure in cirrhosis. Semin Liver Dis 2008; 28: 26-42.
2. Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiologic changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
3. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophagus varices. Br J Surg 1973; 60: 646-9.
4. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.
5. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652-60.
6. Xiol X, Castellote J, Baliellas C, et al. Spontaneous bacterial empyema in cirrhotic patients: analysis of eleven cases. Hepatology 1990; 11: 365-370.
7. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32: 142-53.
8. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
9. Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema: a retrospective review in two military hospitals. Chest 1993; 103: 1502-7.
10. Varkey B, Rose HD, Kutty CP, Politis J. Empyema thoracis during a ten-year period. Analysis of 72 cases and comparison to a previous study (1952-1967). Arch Intern Med 1981; 141: 1771-6.
11. Sese E, Xiol X, Castellote J, et al. Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema. J Clin Gastroenterol 2003; 36: 75-7.
12. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
13. Freeman RB Jr. The model for end-stage liver disease comes of age. Clin Liver Dis 2007; 11: 249-63.
14. Srikureja W, Kyulo NL, Runyon BA, Hu KQ. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005; 42: 700-6.
15. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005; 42 (Suppl.): S100-7.
16. Mishra P, Desai N, Alexander J, Singh DP, Sawant P. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience. J Gastroenterol Hepatol 2007; 22: 1232-5.
17. Neuberger J. Allocation of donor livers - is MELD enough? Liver Transpl 2004; 10: 908-10.
18. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32: 141-56.
19. Ripoll C, Banares R, Rincon D, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005; 42: 793-801.
20. Porcel A, Diaz F, Rendon P, et al. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002; 162: 323-8.
21. Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336-43.
22. Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802-10.
23. Xiol X, Castellví JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996; 23: 719-23.
24. Heo J, Seo YS, Yim HJ, et al. Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study. Gut Liver 2009; 3: 197-204.
25. Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986; 81: 566-77.
26. Liu LU, Haddadin HA, Bodian CA, et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest 2004; 126: 142-8.
27. Xiol X, Castellote J, Cortes-Beut R, et al. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med 2001; 111: 67-9.